Home / Drug shortages / Tafamidis Meglumine Capsule

Tafamidis Meglumine Capsule — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Tafamidis Meglumine Capsule (capsule) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on 09/29/2025.

Shortage Details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0069-1975-40
Dosage Form
Capsule
Presentation
Vyndaqel, Capsule, 20 mg soft gelatin capsules; blister card (120 total capsules) (NDC 0069-1975-40)
Initial Posting
09/29/2025
Revised Date

FDA data resources